Wolverine Trading’s Humacyte HUMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$38.3K Buy
+22,143
New +$43.4K ﹤0.01% 5470
2025
Q1
Sell
-38,839
Closed -$146K 5210
2024
Q4
$198K Sell
38,839
-15,439
-28% -$76.4K ﹤0.01% 4532
2024
Q3
$303K Buy
54,278
+14,248
+36% +$93.9K ﹤0.01% 3610
2024
Q2
$192K Buy
40,030
+21,068
+111% +$110K ﹤0.01% 3862
2024
Q1
$59K Sell
18,962
-1,630
-8% -$5.48K ﹤0.01% 4185
2023
Q4
$58.5K Buy
20,592
+8,731
+74% +$22.4K ﹤0.01% 4222
2023
Q3
$34.8K Buy
+11,861
New +$39.2K ﹤0.01% 4248

Other funds holding HUMA

Wolverine Trading's HUMA Position: Q3 2025 in Review

Wolverine Trading opened a new position in Humacyte (HUMA) in Q3 2025: 22,143 shares worth $38.3K. The stake represents ﹤0.01% of the portfolio and ranks #5470 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in HUMA as recently as Q4 2024.

Wolverine Trading first reported a position in HUMA in Q3 2023 and has held it in 7 quarters since. The position peaked at $303K in Q3 2024. 141 funds tracked by Wall St. Rank hold HUMA as of Q3 2025.

  • Wolverine Trading held 22,143 shares of Humacyte worth $38.3K as of Q3 2025.
  • Humacyte was a new Wolverine Trading position in Q3 2025.
  • Humacyte made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5470 holding.
  • Wolverine Trading first reported a position in Humacyte in Q3 2023 and has held it in 7 quarters since.
  • Wolverine Trading's Humacyte position peaked at $303K in Q3 2024.
  • 141 funds tracked by Wall St. Rank held Humacyte as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.